Drugs MVST IB - part 1

Random Science Quiz

Can you name the drugs from MVST IB - part 1?

Quiz not verified by Sporcle

How to Play
DescriptionDrug nameUse
Potent, irreversible inhibitor of iNOS in activated macrophages
Calcium channel blocker - benzothiazepine
NOS inhibitor - not very selective for different forms
Plasminogen + anisoylated streptokinase
Selective MAO-A inhibitor
Causes development of new blood vessels
ACE inhibitor - prodrug, must be metabolised in liver
Calcium sensitiser - increases cardiac Ca2+ binding efficiency to troponin - inhibits phosphodiesterase III
K channel opener - also hirsutism effects
Non-selective, reversible MAO inhibitor
Non-selective agonist for muscarinic receptors
Intracellular tetravalent polyamine - helps produce inward rectification of K+ channels
Competitive inhibitor of tyrosine hydroxylase
Non-selective alpha-adrenoceptor antagonist
Used experimentally to inhibit dopamine beta-hydroxylase - also inhibits aldehyde dehyddrogenase
Carbonic anhydrase inhibitor
Monoclonal antibody against glycoprotein IIb/IIIa receptor - prevents platelet aggregation - also binds to vitronectin receptor
Illegal drug - blocks NET
Selective MAO-B inhibitor
Direct acting vasodilator - metabolised to NO or cyanide
Involved with providing new blood flow to ischaemic tissues
Non-selective agonist for muscarnic receptors
Orally-acting hypoglycaemic agent - sulphonylurea
Selective inhibitor of NOS in neurons
Local anaesthetic - slow onset/offset - use dependence at low rates of stimulation - class IA antidysrhythmic
Estrogen receptor antagonist
Nitrovasodilator - produces NO - taken sublingually
Partial agonist at alpha-adrenoceptors - 5-HT agonist
Thiazide diuretic - blocks Na/Cl transport in early distal tubule
Depolarising blocker selective for ganglion nicotinic receptor
Regulates expression of multiple angiogenic genes
Inhibits HMG-CoA reductase - also many pleiotropic effects
Mineralocorticoid receptor agonist
Competitive antagonist for ganglionic nicotinic receptor - inactive at NMJ
Progestagen receptor agonist
Muscarinic receptor antagonist - very long duration of action
K channel opener
Uncompetitive inhibitor of phosphatase acting on IP1 --> inositol
Local anaesthetic (ester, weak base) - broken down by BuChE
Beta-1 antagonist used in heart failure
Class III antidysrhythmic - prolongs AP and refractory period
Inhibits liver triglyceride production and VLDL secretion - increases levels of tissue plasminogen activator
Lowers VLDL (and LDL) by stimulating lipoprotein lipase - may activate PPARs
Binds to SNAREs involved in membrane fusion, preventing ACh release
NSAID used to prevent thrombosis
Naturally occurring anticoagulant produced by basophils/mast cells - exposes active site of antithrombin III
Inhibits intestinal absorption of cholesterol - circulates enterohepatically
Acts on imidazoline receptors
Competitively inhibits plasminogen activation - inhibits severe bleeding from excessive clot lysis
Phosphodiesterase III inhibitor - inodilator
Non-selective phosphodiesterase inhibitor
Non-selective phosphodiesterase inhibitor
DescriptionDrug nameUse
Immunosuppressant drug with antiproliferative effects
Binds very tightly to VMAT-2, preventing loading of catecholamines into vesicles
Selective alpha-1 antagonist (slight effect on alpha-2)
Binds to synaptobrevin to prevent vesicle release from inhibitory interneuron synapses with motor neurons
Tricyclic antidepressant - blocks NET
Blocks release of neurotransmitter via phospholipase A2 - localises to membrane by K channel binding moiety
Use-dependent block of ganglionic transmission
alpha-1 antagonist most commonly used
Selective alpha-2 agonist
Selective alpha-1 agonist (some action on beta-1)
Irreversible antagonist at nicotinic NMJ receptors (no effect on ganglionic receptors)
Anion exchange resin - prevents reuptake of bile acids from intestine
Arteriolar vasodilator - unknown mechanism
Blocks transporter carrying ACh into storage vesicles
Inhibits platelet activation by inhibiting binding of ADP to its receptor on platelets
Irreversible anticholinesterase - organophosphorus agent
Non-peptide inhibitor of glycoprotein IIb/IIIa receptor
Class IC antidysrhythmic
K channel opener - also NO donor
Non-selective beta-adrenoceptor antagonist
Selective beta-2 antagonist (slight effect on beta-1)
Co-released with NA or ACh - acts on purinoceptors (P2 > P1)
Cardiac glycoside - inhibits Na/K-ATPase
Local anaesthetic - weak base - use-dependence and voltage-dependence
Beta-1 agonist - weak beta-2 agonist
Selective non-depolarising neuromuscular blocker at NMJ - ester, broken down by spontaneous hydrolysis and plasma esterases
Calcium channel blocker - phenylalkylamine - class IV antidysrhythmic
Indirectly-acting sympathomimetic amine - weak inhibitor of MAO
Depolarising blocker at NMJ
Cholinergic agonist - not selective between nicotinic/muscarinic receptors
Potassium-sparing diuretic - blocks apical Na+ channels in late distal tubule
Tricyclic antidepressant - blocks NET
Non-peptide angiotensin II antagonist - acts on AT1 receptors
SSRI - blocks 5-HT transporter in Uptake 1
A1 receptor antagonist - non-selective phosphodiesterase inhibitor
Experimental cardiac glycoside
Inhibits DOPA decarboxylase in periphery
Cyclic heptapeptide inhibitor of glycoprotein IIb/IIIa receptor
Selective non-depolarising neuromuscular blocking agent at NMJ - long action, not hydrolysed
Progestagen receptor antagonist
Tyrosine kinase inhibitor
PPAR-gamma agonist
Inodilator used to treat canine dilated cardiomyopathy - calcium sensitiser
Very potent alpha-2 agonist
Non-specific endothelin receptor antagonist
Selective antagonist for M1 muscarinic receptors
Competitively inhibits plasminogen activation - inhibits severe bleeding from excessive clot lysis
Quaternary local anaesthetic analogue - only effective if perfused inside cells
Blocks uptake of choline into neurons
Blocks transport of adenosine into cells - phosphodiesterase type V inhibitor
Binds to neurexins, causing massive ACh release from nerve terminals
Selective beta-2 agonist (slight effect on beta-1)
DescriptionDrug nameUse
Reverse inhibition of AChE by organophosphorus agents
Cholinergic agonist - +-isomer hydrolysed by AChE
Acts on imidazoline receptors
Irreversible alpha-adrenoceptor antagonist - blocks Uptake 2 (and Uptake 1 at 10x higher concs)
Glucocorticoid receptor agonist
Beta-adrenoceptor agonist
Alpha-2 antagonist (some effect on alpha-1)
Mineralocorticoid receptor antagonist - potassium-sparing diuretic
Interferes with normal function of microtubule growth
Orally-acting hypoglycaemic agent - sulphonylurea
Reversible anticholinesterase - ionic interaction
Blocks Na channels from exterior - no use-dependence
Converted to alpha-methylNA - released as false transmitter - more potent at alpha-2, less potent at alpha-1
Double chain recombinant human tissue plasminogen activator
ADP-ribosylates alpha-i - prevents activation of Gi in response to stimulation
Muscarinic receptor agonist
Nitrovasodilator - produces NO - metabolised in liver to active drug
Medium 'reversible' anticholinesterase - binds to esteratic site and carbamoylates ACh
Blocks release of NA evoked by APs (repeated low doses/aftermath of large dose) - indirect sympathomimetic actions (large doses)
ADP-ribosylates alpha-s - inhibits GTPase activity - sustained activation of adenylyl cyclase
Glucocorticoid receptor antagonist
Inhibits clotting by inhibiting synthesis of factors II, VII, IX, IX and regulatory proteins C, S, Z
Competitive antagonist for ganglionic nicotinic receptors - inactive at NMJ
Calcium channel agonist - dihydropyridine
Binds to plasminogen activator, increasing generation of plasmin
Nitrovasodilator - produces NO
Blocks If current in SA node
COMT inhibitor
Selective inhibitor of phosphodiesterase type V (selectively breaks down cGMP)
Irreversible anticholinesterase - activated by replacement of sulphur atom with oxygen, deoxified by plasma carboxylesterases
Calcium channel antagonist - dihydropyridine - affects L-type but not T-type channels
Potassium-sparing diuretic - blocks apical Na+ channels in late distal tubule
Nicotinic receptor antagonist - relatively non-selective between NMJ and ganglion at clinical doses
ACE inhibitor
Irreversibly alkylates muscarinic receptor
Angiotensin II partial agonist
Selective alpha-2 antagonist (slight effect on alpha-1)
K channel opener
Mild partial beta-1 agonist
Indirectly acting sympathomimetic amine - converted to octopamine by DBH - found in various foodstuffs
Local anaesthetic - uncharged
Beta-1 antagonist used in heart failure
Slightly selective alpha-2 agonist (also alpha-1 actions) - omitting dose can lead to rebound hypertension
Selective beta-1 antagonist (slight effect on beta-2)
Estrogen receptor agonist
Combined alpha- and beta-adrenoceptor antagonist
Depolarising blocker selective for NMJ nicotinic receptor - very short duration of action, broken down by BuChe - deficiency in enzyme activity can lead to prolonged action
Selective antagonist for M3 muscarinic receptor
Phosphodiesterase III inhibitor - inodilator
Osmotic diuretic - filtered at glomerulus, not reabsorbed
Loop diuretic - blocks Na/K/2Cl transport in thick ascending limb
Single chain recombinant human tissue plasminogen activator

Friend Scores

  Player Best Score Plays Last Played
You You haven't played this game yet.

You Might Also Like...


Created May 3, 2010ReportNominate
Tags:description, drug